Heba, a 49-year-old pathologist from Egypt, learned she had pancreatic cancer in Alexandria in 2025. At West China Hospital, scans later showed that the tumor surrounded the point where several major veins meet, making surgery particularly difficult.
Heba underwent several rounds of chemotherapy and sought opinions in Alexandria and Cairo. The doctors she consulted advised against surgery because of the difficulty and risks of operating around the affected vessels, according to Sichuan Daily’s Chuanguan News.
Ahmed Elgendi, an Egyptian surgeon who had trained at West China Hospital, recommended that Heba seek an assessment there. She was admitted in Chengdu on April 5, 2026. After a multidisciplinary review on April 9, she chose to have surgery in Chengdu.
On April 16, the team at West China Hospital, Sichuan University, operated for about six hours. The hospital’s Chinese-language report said the surgeons removed the tumor while preserving part of the pancreas, the spleen and the right colon. Chuanguan News reported that Heba was eating and talking by April 21. The hospital described her early recovery on April 22. Her long-term outcome remains unknown.
Sources
China Care did not provide the care described. This story does not imply a relationship with the patient or hospital, or that China Care can arrange the same treatment. Individual outcomes do not predict other patients’ results. This is editorial information, not medical advice.